启明星 | 全球机器人服务智能体领军企业云迹科技成功登陆港交所 | Bilingual

Swipe Left for the English Version

北京时间10月16日，**启明创投投资企业、全球机器人服务智能体领军企业云迹科技成功登陆港交所。**云迹科技（02670.HK）发行价为95.6港元/股，开盘价142.8港元/股，市值98.13亿港元。

2021年，启明创投领投云迹科技C轮融资，并在后续融资中继续支持公司发展。

云迹科技创立于2014年，主要为客户提供适应性强及可拓展的机器人及功能套件，辅以AI数字化系统服务。 云迹科技专注研发的机器人服务智能体是一个搭载于机器人上的智能自动化系统，其集成AI技术在直接与用户交互的过程中，提供以人为本的端到端服务，通过持续学习与自适应优化，全面提升体验品质及营运效率。

凭借领先的产品和技术，以及简约灵活的综合产品服务组合，云迹科技的机器人服务智能体广泛应用于酒店、工厂、医院、楼宇等多元场景。截至目前，云迹科技在全球累计部署酒店3.4万家，2024年，单日在线运行的机器人设备最高达3.6万台，全年累计完成约5亿次服务。大多数连锁酒店都将云迹科技的机器人产品作为智能化升级的第一选择，公司在酒店客户市场占有率为国内第一，高于第二至五名总和。

云迹科技创始人、董事长、总裁支涛表示：" 此次IPO是市场对服务机器人商业化价值的充分肯定，标志着机器人服务智能体向规模化落地迈出了关键一步。未来，云迹科技将持续夯实'大脑+四肢'的全栈研发能力，深化酒店场景优势并拓展多元商业场景，吸引全球顶尖人才，推动机器人技术与垂直行业实现更深刻的融合，让智能服务走进千家万户。"

启明创投主管合伙人周志峰表示："启明创投在2021年就看到了室内无人化技术的成熟，坚决布局酒店这样的刚需场景。 自投资以来见证了云迹科技将技术与场景深度融合，借助领先的机器人产品重新定义了消费者体验。展望未来，此次IPO将为云迹科技拓展全球市场提供助力，新的具身智能等技术也将帮助云迹科技这样的企业落地更丰富的场景。启明创投将发挥全球视野和产业生态资源优势，支持优质企业拓展技术边界和商业场景，将中国创新成果推向世界舞台。"

Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange

Yunji Technology, a global leader in the hospitality robotic-based AI agents market and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock Exchange on October 16th. Yunji Technology (SEHK:2670) was issued at HK$95.6 per share and opened at HK$142.8 per share, with a market capitalization of HK$9.81 billion.

Qiming led Yunji Technology's Series C funding round in 2021 and has continued to support the company's growth through subsequent financing round.

Founded in 2014, Yunji Technology offers adaptive and scalable robots and functional kits, complemented by services under AI digitalization system. The company primarily focuses on the development of hospitality robotic-based AI agents, intelligent and automated systems embodied on robots that integrate AI technologies to provide human-centric and end-to-end services when interacting directly with users. These agents enhance experiences and operational efficiency through continuous learning and adaptation.

Leveraging its robust products and technologies, along with a comprehensive product-service mix built for simplicity and flexibility, Yunji Technology's hospitality robotic-based AI agents are adaptable to diverse scenarios, including hotels, factories, hospitals, and buildings. To date, Yunji Technology has deployed its service robots in over 34,000 hotels worldwide. In 2024, the company's robots have reached a peak of 36,000 units operating online in a single day, completing approximately 500 million service interactions annually. Most major hotel chains have chosen Yunji Technology's robotic solutions as their first choice for intelligent upgrades, making the company the No. 1 player in China's hotel robotics market, with a market share larger than the combined total of the second to fifth competitors.

"This IPO is strong validation from the market of the commercial value of service robots, and it marks a critical milestone in our journey toward scaled deployment of hospitality robotic-based AI agents," said Tao Zhi, Founder, Chairwoman, and President of Yunji Technology. "Going forward, we'll continue strengthening our full-stack R&D capabilities in both brains and limbs, deepening our leadership in the hotel sector while expanding into new commercial verticals. We're committed to attracting world-class talent and driving deeper integration between robotics and industry-specific applications to bring intelligent services to households around the globe."

Alex Zhou, Managing Partner of Qiming Venture Partners, said, "In 2021, Qiming recognized the maturation of indoor autonomous technology and made strategic investments in high-demand markets such as the hotel sector. We have witnessed Yunji Technology effectively bridge technology and real-world applications, enhancing customer experiences through innovative robotic solutions. With this IPO, Yunji Technology is well-positioned to accelerate its expansion into global markets, while emerging technologies like embodied AI are expected to open new application opportunities. At Qiming, we remain committed to supporting exceptional companies by leveraging our global vision and industry resources, helping them push technological boundaries and deliver innovative solutions to international markets."

---

往期回顾

启明星 | 云迹科技完成C轮融资，启明创投领投 启明观点 | 启明创投周志峰：用投资的方式推动中国科技创新 启明荣誉 | 启明创投入选最科技T50——中国先锋科技投资机构50强榜单

启明创投成立于2006年。目前，启明创投旗下管理11只美元基金，7只人民币基金，已募管理资产总额达到95亿美元。自成立至今，专注于投资科技(Technology)、医疗创新(Healthcare)等行业早期和成长期的优秀企业。

截至目前，启明创投已投资超过580家高速成长的创新企业，其中有超过210家分别在美国纽交所、纳斯达克，香港交易所，上交所及深交所等交易所上市，或通过并购等方式退出，有80多家企业成为行业公认的独角兽或超级独角兽企业。

启明创投投资企业中，很多已经成长为各自领域中最具影响力的公司，包括小米集团（01810.HK）、美团（03690.HK）、哔哩哔哩（NASDAQ:BILI, 09626.HK）、知乎（NYSE:ZH, 02390.HK）、石头科技（688169.SH）、优必选（09880.HK）、文远知行（NASDAQ:WRD）、海博思创（688411.SH）、影石创新（688775.SH）、云知声（09678.HK）、甘李药业（603087.SH）、泰格医药（300347.SZ, 03347.HK）、再鼎医药（NASDAQ:ZLAB, 09688.HK）、康希诺生物（688185.SH, 06185.HK）、Schrödinger（NASDAQ:SDGR）、惠泰医疗（688617.SH）、三友医疗（688085.SH）、艾德生物（300685.SZ）、贝瑞基因（000710.SZ）、神州细胞（688520.SH）、圆心科技、英矽智能、宜联生物、礼新医药、智谱、阶跃星辰、壁仞科技等。